Share This Page
Drug Price Trends for VERAPAMIL SR
✉ Email this page to a colleague
Average Pharmacy Cost for VERAPAMIL SR
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| VERAPAMIL SR 180 MG CAPSULE | 00591-2882-01 | 1.07246 | EACH | 2024-12-18 |
| VERAPAMIL SR 360 MG CAPSULE | 00591-2886-01 | 4.04431 | EACH | 2024-12-18 |
| VERAPAMIL SR 240 MG CAPSULE | 00591-2884-01 | 1.09451 | EACH | 2024-12-18 |
| VERAPAMIL SR 120 MG CAPSULE | 00591-2880-01 | 0.92992 | EACH | 2024-12-11 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Verapamil SR
Introduction to Verapamil SR
Verapamil SR, a calcium channel blocker, is widely used for treating high blood pressure, angina, and certain heart rhythm disorders. It works by relaxing blood vessels and reducing the heart's workload.
Global Market Overview
The global Verapamil Hydrochloride market, which includes Verapamil SR, is experiencing significant growth. Here are some key points from the market analysis:
- Market Size and Growth: The global Verapamil Hydrochloride market size was substantial in 2023, with a projected compound annual growth rate (CAGR) from 2024 to 2031. This growth is driven by increasing demand for cardiovascular treatments and the expanding geriatric population[1].
- Segmentation: The market is segmented by type and application. The purity above 98% segment accounted for a noticeable share of the global market in 2023 and is expected to grow significantly. The tablet segment, particularly extended-release formulations like Verapamil SR, is anticipated to expand at a significant CAGR throughout the forecast period[1].
Market Drivers and Opportunities
Several factors are driving the growth of the Verapamil SR market:
- Increasing Prevalence of Cardiovascular Diseases: The rising incidence of hypertension, angina, and other cardiovascular conditions is a major driver. As the global population ages, the demand for effective treatments like Verapamil SR is expected to increase[1].
- Advancements in Formulations: Extended-release formulations like Verapamil SR offer better patient compliance and therapeutic outcomes, making them more attractive to both patients and healthcare providers[1].
- Generic Versions: The availability of generic versions of Verapamil SR has made the drug more accessible and affordable, contributing to market growth[2][5].
Market Restraints and Challenges
Despite the growth, there are several challenges facing the Verapamil SR market:
- Price Volatility: Prices for Verapamil SR can vary significantly depending on the region and availability. For instance, U.S. prices for prescription drugs, including Verapamil SR, are generally higher than in other high-income countries[3].
- Supply Chain Disruptions: Recent disruptions, such as the shortage of MYLAN-VERAPAMIL SR due to manufacturing issues, can impact market stability and patient access[4].
Price Projections
The prices of Verapamil SR vary based on the dosage form, strength, and quantity:
- Extended-Release Oral Capsules:
- 100 mg/24 hours: Prices start from around $162.50 for 30 capsules.
- 120 mg/24 hours: Prices start from around $109.78 for 100 capsules.
- 180 mg/24 hours: Prices start from around $129.63 for 100 capsules.
- 200 mg/24 hours: Prices start from around $621.76 for 100 capsules[2].
- Extended-Release Oral Tablets:
- 180 mg/12 hours: Prices start from around $26.22 for 90 tablets.
- 240 mg/12 hours: Prices start from around $21.57 for 30 tablets[2].
Regional Price Comparisons
Prices for Verapamil SR and similar drugs vary significantly across different regions:
- United States vs. Other Countries: U.S. prices for prescription drugs, including Verapamil SR, are generally higher than in other high-income countries. For example, U.S. prices can be up to 229% higher than Canadian prices and up to 1,028% higher than Turkish prices[3].
- Generic vs. Brand Name: Generic versions of Verapamil SR are often more affordable and can be priced lower than brand-name versions, making them a more accessible option for many patients[2][5].
Competitive Landscape
The market for Verapamil SR is competitive, with several key players:
- Bharat Pharmaceuticals: Known for its strong product portfolio and global market presence.
- Vpl Chemicals Pvt Ltd: Focused on expanding its business in the global market through strategic initiatives.
- Mylan Pharmaceuticals ULC: A significant player, especially with its MYLAN-VERAPAMIL SR product, although it has faced recent supply chain disruptions[1][4].
Consumer Behavior and Preferences
Consumer behavior plays a crucial role in the market dynamics of Verapamil SR:
- Patient Compliance: Extended-release formulations are preferred due to their convenience and better compliance rates.
- Cost Sensitivity: Patients often opt for generic versions due to their affordability, which has driven the growth of the generic segment[1][2].
Key Takeaways
- The global Verapamil Hydrochloride market, including Verapamil SR, is expected to grow significantly due to increasing demand for cardiovascular treatments.
- Extended-release formulations are gaining traction due to better patient compliance.
- Price volatility and supply chain disruptions are key challenges.
- Generic versions are more affordable and widely adopted.
- Regional price differences are significant, with U.S. prices generally being higher.
FAQs
1. What is Verapamil SR used for? Verapamil SR is used to treat high blood pressure, angina, and certain heart rhythm disorders by relaxing blood vessels and reducing the heart's workload.
2. How does the price of Verapamil SR vary? Prices for Verapamil SR vary based on the dosage form, strength, quantity, and region. U.S. prices are generally higher than in other high-income countries.
3. Are there generic versions of Verapamil SR available? Yes, generic versions of Verapamil SR are available and are often more affordable than brand-name versions.
4. What are the key drivers of the Verapamil SR market? The increasing prevalence of cardiovascular diseases, advancements in formulations, and the availability of generic versions are key drivers of the market.
5. Have there been any recent supply chain disruptions for Verapamil SR? Yes, there have been recent shortages, such as the MYLAN-VERAPAMIL SR shortage due to manufacturing disruptions, which have impacted market stability and patient access.
Sources
- Cognitivemarketresearch.com: Verapamil Hydrochloride Market Report 2024 (Global Edition)
- Drugs.com: Verapamil Prices, Coupons, Copay Cards & Patient Assistance
- ASPE.HHS.GOV: International Prescription Drug Price Comparisons: Estimates Using a Price Index Approach
- Drugshortagescanada.ca: Drug Shortage Report for MYLAN-VERAPAMIL SR
- Drugs.com: Calan SR Prices, Coupons, Copay Cards & Patient Assistance
More… ↓
